TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT03903068

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NEXALIN ADI AC stimulator
Description: When the patient is ready for the treatment, place an electrode on the patient's forehead and place an electrode in each of the mastoid areas behind each ear. The three electrodes are placed in this way to enhance the performance of the Nexalin ADI device. When the device is activated, there will be a weak current passing through the forehead electrode and each mastoid electrode. The current intensity of Nexalin ADI treatment defaults to 15.00 mA and the duration defaults to 40 minutes. Both are preset to default parameters and cannot be changed.
Study: NCT00949910

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Erlotinib
Description: Erlotinib will be given orally as 150 milligrams (mg) once daily until unacceptable toxicity, disease progression, or withdrawal for any other reason.
Study: NCT02897869

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: POL7080
Description: 7 doses of POL7080 alone over 2.5 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: POL7080
Description: 7 doses of POL7080 alone over 2.5 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amikacin
Description: 3 doses of Amikacin alone over 2.5 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amikacin
Description: 3 doses of Amikacin alone over 2.5 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: POL7080 + Amikacin
Description: 7 doses of POL7080 and 3 doses of Amikacin over 2.5 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: POL7080 + Amikacin
Description: 7 doses of POL7080 and 3 doses of Amikacin over 2.5 days
Study: NCT01752972

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Spirulina
Description: 10 g/day orally for 12 weeks

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Spirulina
Description: 10 g/day orally for 12 weeks

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Spirulina
Description: 10 g/day orally for 12 weeks
Study: NCT01277497

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sevelamer carbonate
Description: Sevelamer carbonate 1,600 mg three times daily with meals

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Calcium acetate
Description: Calcium acetate 1,334 mg three times daily with meals for 12 weeks
Study: NCT02621619

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IV acetaminophen + 0.5 mg IV hydromorphone
Description: 1 gram (100 ml) IV acetaminophen in addition to 0.5 mg IV hydromorphone

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal saline + 0.5 mg IV hydromorphone
Description: 100 cc normal saline placebo in addition to 0.5 mg IV hydromorphone
Study: NCT04213508

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Isotonic Saline ( 0.9% Sodium Chloride Saline)
Description: 0.9% Sodium Chloride (NaCl) saline will be used as nasal irrigation for two groups. (first groups 2 times per day and second group 5 times per day ). Each time, amount of 50 ml of saline will be used in each nostril ( 100 ml for both nostrils per time) . So, in total 500 ml of 0.9% Sodium Chloride (NaCl) saline will be used daily for 1 month .

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Isotonic Saline ( 0.9% Sodium Chloride Saline)
Description: 0.9% Sodium Chloride (NaCl) saline will be used as nasal irrigation for two groups. (first groups 2 times per day and second group 5 times per day ). Each time, amount of 50 ml of saline will be used in each nostril ( 100 ml for both nostrils per time) . So, in total 500 ml of 0.9% Sodium Chloride (NaCl) saline will be used daily for 1 month .

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Hypertonic Saline ( 3% Sodium Chloride Saline)
Description: 3% Sodium Chloride (NaCl) saline will be used as nasal irrigation for two groups. (first groups 2 times per day and second group 5 times per day ). Each time, amount of 50 ml of saline will be used in each nostril ( 100 ml for both nostrils per time). So, in total 200 ml of 3% Sodium Chloride (NaCl) saline will be used daily for 1 month .
Study: NCT01401621

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Scratchoff Prompt: Name of Test
Description: A prompt will have the recipient scratch off the message that reveals the name of the test that the recipient needs

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Scratchoff Prompt: Call to Action
Description: A prompt will have the recipient scratch off the message to find out how to follow the recommendation that the test be received.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Control
Description: No scratch-off element
Study: NCT02214784

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Active Neurotech Vital
Description: 12 weeks treatment for 30 minutes per day, 5 days out of 7.

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Modified Neurotech Vital Device
Description: 12 weeks treatment for 30 minutes per day for 5 days out of 7.
Study: NCT03866720

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Carbohydrate rich breakfast
Description: A porridge breakfast meal fed at a carbohydrate delivery rate of 7.3 mg/kJ of each participants resting metabolic rate.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Whey protein enriched breakfast
Description: A porridge breakfast meal in which 15 grams of whey protein is substituted in place of carbohydrate and a small portion of fat.
Study: NCT02075671

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aminolevulinic acid topical solution 20%
Description: Intervention used in the experimental arm only

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Blu-U Light Therapy
Description: Intervention used in experimental and sham arms

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Blu-U Light Therapy
Description: Intervention used in experimental and sham arms
Study: NCT03168893

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Deep brain stimulation ON
Description: Infinity model of deep brain stimulation is placed ( 2 brain elecrodes and subcutaneus generator ) under general anhestesia. The system is activated
Study: NCT03903068

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Pseudo-stimulator
Description: When the patient is ready for the treatment, place an electrode on the patient's forehead and place an electrode in each of the mastoid areas behind each ear. When the device is started, no current flows through the electrodes, but the instrument's operating procedures, parameter displays, and prompts are the same as for a real instrument.
Study: NCT00444912

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: G-CSF plus plerixafor
Description: Participants underwent mobilization with G-CSF (7.5 µg/kg twice daily) for 4 days, administered by subcutaneous (sc) injection. On the evening of Day 4, participants received a dose of plerixafor (240 µg/kg), administered by SC injection. On Day 5, participants returned to the clinic and received a morning dose of G-CSF (7.5 µg/kg) and underwent apheresis approximately 10 to 11 hours after the dose of plerixafor. Participants were to continue to receive G-CSF twice daily and to receive the evening dose of plerixafor followed by apheresis the following morning for a maximum of 4 aphereses or until ≥ 5\*10\^6 CD34+ cells/kg were collected.
Study: NCT04213508

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Hypertonic Saline ( 3% Sodium Chloride Saline)
Description: 3% Sodium Chloride (NaCl) saline will be used as nasal irrigation for two groups. (first groups 2 times per day and second group 5 times per day ). Each time, amount of 50 ml of saline will be used in each nostril ( 100 ml for both nostrils per time). So, in total 200 ml of 3% Sodium Chloride (NaCl) saline will be used daily for 1 month .
Study: NCT04000347

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 2.5% benzoyl peroxide gel
Description: 2.5% benzoyl peroxide gel was given to patients for 2 weeks

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 5% benzoyl peroxide gel
Description: 5% benzoyl peroxide gel was given to patients for 2 weeks
Study: NCT02890043

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: robot-assisted spine surgery
Description: robot-assisted spine surgery using Tirobot system

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: free-hand surgery
Description: traditional free-hand surgery

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TiRobot system
Description: a robot-assisted spine surgery system
Study: NCT01928082

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Transdermal estradiol
Description: 4 weeks of Vivelle-Dot 0.05 mg/day followed by 4 weeks of Vivelle-Dot 0.10 mg/day
Study: NCT02995122

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BAY987516
Description: Each 50 cm\*2 test site area of a subject requires 100 mg of a test material to obtain a standard 2 mg/cm\*2 test application.~(Formulation Code: Z43-090)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SPF Control
Description: Each 50 cm\*2 test site area of a subject requires 100 mg of a test material to obtain a standard 2 mg/cm\*2 test application.
Study: NCT04546464

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Therapeutic Recreation Program
Description: The experimental recreation program, which consisted of two sessions per week and lasted approximately~1 hour each session, lasted for 8 weeks between May 2019 and June 2019 for the adolescents in the experimental group. The Therapeutic Recreation Activity Program, which consists of 16 sessions, is organized according to the self-determination and entertainment development model. This model aims to provide individual development and prosperity by creating an entertaining environment with therapeutic recreation. According to the degree of enjoyment, activity improves freedom of choice, preferences and ability to express oneself. Pleasure is a feeling that the participant feels deeply during therapeutic recreation. Provides entertainment experience. Pleasure increases individual motivation to participate, as well as making the best use of physical, social and emotional conditions
Study: NCT04457193

Intervention type: DEVICE
Intervention: TIF
Description: Transoral Incisionless Fundoplication (TIF) is an endoscopic procedure that mechanically creates fundoplication similar to traditional operative Nissen fundoplication. The role of TIF in patients with BE whom underwent successful endoscopic ablation has not been fully investigated.
Study: NCT01473329

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Structured Diabetes Education
Description: The intervention group received a structured DSME course adapted from 15. The course was composed by weekly 2 hour meetings for five weeks total hours group of 10 patient and reinforcement meetings every 4 months, for one year
Study: NCT00565214

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Group 1
Description: The treatment plan involves the administration of a combination of 3 vitamins (vitamin C 1000 mg, vitamin E 400 IU, selenomethionine 400 μg) to study volunteers in a 2:1 randomization, Vitamins are to be taken orally, once a day, for a duration of 30 days.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Group 2
Description: The treatment plan involves the administration of a combination of 3 placebos to be taken orally, once daily for a duration of 30 days.
Study: NCT02214485

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: integrated care
Description: Participants visit the study site with health education, social activities, warm up, stretch, and low intensity resistance exercise for about 1 hour per week. If any medical problems or functional decline suspected during the visit, the case manager refers participants to their primary care physicians for further managements.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: lower extremity strength training
Description: Participants receive 2 sessions of 30-minute lower extremity strength straining using isotonic strength training machines each week. The intensity is set at 60-80% of 1 repetition maximum (RM). Evaluation of the exercise protocol are repeated every 2 weeks for individualized adjustments.
Study: NCT01626989

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: BiPAP auto Advanced
Description: Auto Servo Ventilation Device

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BiPAP auto SV4
Description: Auto Servo Ventilation Device
Study: NCT02075671

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo vehicle only
Description: Intervention only includes the placebo vehicle solution
Study: NCT03365011

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nitrous oxide gas for inhalation
Description: Nitrous oxide gaseous mixture (50% nitrous oxide and 50% oxygen) for 40 minutes duration under anesthesia supervision with monitoring according to standards set by the American Society of Anesthesiologists.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo gas for inhalation
Description: Placebo gaseous mixture (50% nitrogen and 50% oxygen) for 40 minutes duration under anesthesia supervision with monitoring according to standards set by the American Society of Anesthesiologists.
Study: NCT02978820

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: SEAS exercise
Description: Patient were referred by medical doctor with a prescription of brace and exercise training for their moderate scoliotic curves. Patients were randomly divided into two groups. The SEAS group received SEAS exercises one times in a week for four months. In addition patients in SEAS groups were wearing spinal brace for their scoliosis in this period

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CS exercise
Description: Patient were referred by medical doctor with a prescription of brace and exercise training for their moderate scoliotic curves. Patients were randomly divided into two groups. The CS group received core stabilization exercise training one times in a week for four months. In addition patients in SEAS groups were wearing spinal brace for their scoliosis in this period
Study: NCT02319395

Intervention type: GENETIC
Intervention: Blood Sampling and DNA collection
Description: One blood sampling during the study. A small number (1 to 5) of markers type tag SNPs or coding SNP  (single nucleotide polymorphism, SNP) will be selected for each of the selected genes, for a total of 50 markers (representing 20 to 25 genes). Non-silent coding SNP, that may have a functional effect, will be included as a priority. Genotyping is carried out by the method of genotyping VeraCode Goldengate.

Intervention type: GENETIC
Intervention: Blood Sampling and DNA collection
Description: One blood sampling during the study. A small number (1 to 5) of markers type tag SNPs or coding SNP  (single nucleotide polymorphism, SNP) will be selected for each of the selected genes, for a total of 50 markers (representing 20 to 25 genes). Non-silent coding SNP, that may have a functional effect, will be included as a priority. Genotyping is carried out by the method of genotyping VeraCode Goldengate.
Study: NCT01064154

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carvedilol
Description: Carvedilol Tablets 25 mg

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carvedilol
Description: Carvedilol Tablets 25 mg
Study: NCT00222989

Intervention type: DRUG
Group type: OTHER
Intervention: PPI
Study: NCT03168893

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Deep brain stimulation OFF
Description: Infinity model of deep brain stimulation is placed ( 2 brain elecrodes and subcutaneus generator ) under general anhestesia. The system is not activated
Study: NCT02272946

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Canakinumab
Description: 150mg Canakinumab received subcutaneously
Study: NCT04365894

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Transformative learning theory
Description: According to the transformative learning theory, learning methods in education should include four activities as investigate, collaborative, higher-order thinking and interactive learning activities
Study: NCT03428841

Intervention type: PROCEDURE
Intervention: Audiometry

Intervention type: PROCEDURE
Intervention: Audiometry
Study: NCT00628758

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Symbicort TBH - Turbuhaler
Description: Symbicort Single Inhaler Therapy ( Turbuhaler 160/4.5 microgram, 1 inhalation bid + as needed)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: beta-II-agonist, inhale steroid
Description: Salbulin inh. 200-400 dosage 100 microgram (mcg)/dosage Salbutamol Sustained Release(SR)capsule 4 mg/8 mg Salbutol tablet (tb) 2 mg Salbutol forte syrup 2 mg/5 ml Ventolin tb, syrup, intravenous(IV),5mgx10 ampule(amp) Ventolin inhaler (inh) 200 dosage, 100 mcg/dosage Ventolin nebul 2.5 mg Volmax tb 4 mg/8 mg Vent-o-sal inh 100 mcg/200 dosage Combivent inh 100 mcg/dosage Combivent neb 2.5 mg/dosage Bricanyl tb 2.5 mg Bricanyl durules ret tb 5 mg Bricanyl syrup 30mg Bricanyl inhaler 0.25 mg/dosage, 400 dosage Bricanyl turbuhaler 0.5 mg/dosage, 200dosage
Study: NCT01564667

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Attention Bias Modification Training Protocol
Description: Attention Bias Modification computerized training sessions administered 2 times per week for 4 weeks making a total of 8 training sessions.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Attention Bias Modification Training Protocol
Description: Attention Bias Modification computerized training sessions administered 2 times per week for 4 weeks making a total of 8 training sessions.
Study: NCT03779893

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: BioCoat® by Premier®.
Description: Bioactive pits and fissure sealant

Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: 3M™ Clinpro™ Sealant.
Description: conventional pits and fissure sealant
Study: NCT03496727

Intervention type: PROCEDURE
Intervention: Serratus anterior plane block
Description: Serratus anterior plane block+patient controlled analgesia

Intervention type: PROCEDURE
Intervention: Patient controlled analgesia
Description: Patient-controlled analgesia
Study: NCT03181074

Intervention type: OTHER
Intervention: Non-Interventional
Description: Non-Interventional
Study: NCT00988260

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ganirelix
Description: Ganirelix 0.125 mg subcutaneous daily (SC OD) for up to 14 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ganirelix
Description: Ganirelix 0.25 mg subcutaneous daily (SC OD) for up to 14 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ganirelix
Description: Ganirelix 0.5 mg subcutaneous daily (SC OD) for up to 14 days
Study: NCT02535637

Intervention type: OTHER
Intervention: Exclusively breastfeed
Description: There is no intervention other than mothers must exclusively breastfeed.
Study: NCT06377722

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cabozantinib
Description: This study tries to clarify whether Cabozantinib could be a safe and effective preoperative treatment in patients with advanced RCC who were candidates for removing a part or all of their kidney.
Study: NCT00438893

Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: Dietary portfolio of cholesterol-lowering foods
Description: A plant based dietary portfolio providing plant sterols (1.0g/1000 kcal), soy protein (22.5g/1000 kcal, viscous fibers 10 g/1000 kcal and almonds 22.5g/1000 kcal)
Study: NCT05100433

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ultrasonic irrigation
Description: Ultrasonic irrigation will be used as a complementary step to chemomechanical procedures to test whether it can improve root canal disinfection.
Study: NCT04828369

Intervention type: PROCEDURE
Intervention: EUS-guided coil embolization combined with endoscopic cyanoacrylate injection
Description: (1) Standard diagnostic endoscopy was first performed. Fundal varices were assessed using the classification of Sarin's. (2) intraluminal water filling of the gastric fundus to use EUS to assess the anatomy of gastric varices, observe the blood flow, scan the portal venous system, left renal vein, confirm the location of the shunt, and measure the diameter of the shunt. (3) Punctured the gastric fundal variceal vein at the lower esophagus near the cardia and placed the coil into the shunt and immediately injected with sclerosant and cyanoacrylate under the guidance of EUS. (4) Sclerosant and cyanoacrylate were injected into the gastric fundal varices by a sandwich method (cyanoacrylate, sclerosant and cyanoacrylate) via endoscope. (5) After the injection, use color Doppler ultrasound to observe the blood flow in the variceal veins to evaluate the embolization effect.

Intervention type: PROCEDURE
Intervention: balloon-occluded retrograde transvenous obliteration
Description: (1)A balloon occlusive catheter was inserted into the shunt via the right femoral vein. (2)Investigators performed angiography to evaluate the size and location of GV and the shunt during balloon occlusion. Shunt was occluded by Fogarty balloon. The diameter of the balloon was chosen according to the diameter of shunt. (3)Then investigators injected sclerosant into the portosystemic shunt. (4)Finally, the balloon left in place for 24 hours was gradually deflated when complete occlusion of blood flow of the target shunt was achieved.
Study: NCT01469572

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pasireotide
Description: Pasireotide is given as an injection.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Sir-sphere Radioembolization
Description: A catheter will be placed in a branch of the hepatic artery (liver) that supplies the tumor with blood. Radioactive beads will be injected into the tumor through the catheter.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Everolimus
Description: Given orally every day for the duration of the study
Study: NCT02675179

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: EOS
Description: Pelvimetry will be performed with the new EOS technique of diagnosis to measure the diameter of the basin.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Spiral CT pelvimetry
Description: Pelvimetry will be performed with the spiral CT technique. It is the technique usually used.